Company Overview and News

 
Manitou Gold Signs Binding Agreement to Acquire Goudreau-Lochalsh “Rockstar” Property

2018-03-21 globenewswire
SUDBURY, Ontario, March 21, 2018 (GLOBE NEWSWIRE) -- Manitou Gold Inc. (TSX-V:MTU) (the “Company” or “Manitou”) announces that it has entered into a binding purchase agreement with Argo Gold Inc. (the “Vendor”) to purchase the property known as the “Rockstar” Property, comprised of 16 unpatented mining claims located in Jacobson and Riggs Townships, Ontario (collectively, the “Property”).
Upvote Downvote

 
Sonoro Closes Cerro Caliche Expansion Agreement

2018-03-20 globenewswire
VANCOUVER, British Columbia, March 20, 2018 (GLOBE NEWSWIRE) -- Sonoro Metals Corp., (“Sonoro”) (TSXV:SMO) (OTCQB:SMOFF), announces that its Mexican subsidiary, Minera Mar De Plata, SA de C.V. has executed a formal option agreement (the “Rosario Option Agreement”) with a resident of Tucson, Arizona (the “Vendor”), to acquire a 100% interest in the 403.5 hectare Rosario group of concessions (“Rosario”) on the terms initially disclosed in a news release dated March 5, 2018.
Upvote Downvote

1
Argonaut: Reserve Projections For Magino Mine Should Be Treated With Caution

2018-03-06 seekingalpha
Argonaut Gold boasts its Magino Mine, an advanced development project in Ontario, contains reserves totaling 59-million tonnes of ore and over 2-million ounces of gold. Given the structure of the deposit and Argonaut's reluctance to reveal how it determined true widths of ore bodies, a closer look at these estimates casts doubt as to their accuracy.
Upvote Downvote

 
Argonaut Gold Inc 2017 Q4 - Results - Earnings Call Slides

2018-02-26 seekingalpha
The following slide deck was published by Argonaut Gold Inc in conjunction with their 2017 Q4 earnings call.
Upvote Downvote

 
Argonaut Gold's (ARNGF) CEO Peter Dougherty on Q4 2017 Results - Earnings Call Transcript

2018-02-23 seekingalpha
Good morning, my name is Krista, and I will be your conference operator today. At this time, I would like to welcome everyone to the Argonaut Gold's 2017 Fourth Quarter Financial Results Conference Call. [Operator Instructions]. Mr. Pete Dougherty, President and CEO of Argonaut Gold, you may begin your conference, sir.
Upvote Downvote

 
Vior Announces Sudden Passing of New Director

2018-02-16 marketwired
Vior today announces with great sadness, the sudden passing of its recently appointed director Mr. Gary Freeman.
Upvote Downvote

 
Trump Throws Cold Water On The Gold Rally

2018-02-09 seekingalpha
While the "bounce" in the USD has been anemic, the precious metals and mining stocks have reacted very negatively.
Upvote Downvote

 
ARNGF / Argonaut Gold Inc - Stock Institutional Ownership and Shareholders - Fintel.io

2018-01-30 fintel.io
Argonaut Gold Inc (OTC:ARNGF) has 1 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 37,844 shares. Largest shareholders include Old Mission Capital Llc, and Old Mission Capital Llc.
Upvote Downvote

 
Research Reports on New Gold, Dalradian Resources, Eastmain Resources, and Argonaut Gold

2017-12-13 accesswire
LONDON, UK / ACCESSWIRE / December 13, 2017 / Active-Investors free stock reports for this morning include these Toronto Exchanges' equities from the Metals & Mining industry: New Gold, Dalradian Resources, Eastmain Resources, and Argonaut Gold. Access our complimentary up-to-the-minute research reports by becoming an online member now:
Upvote Downvote

 
Resource Sector Digest: Torex Gold - I See Nothing

2017-12-06 seekingalpha
Sergeant Schultz is not a good role model for resource sector investors, as will be discussed in this week's...
Upvote Downvote

1
Resource Sector Digest: Barrick Gold - Call Us Crazy, Too

2017-11-29 seekingalpha
We compare the performance of the Big Four gold miners and support the bull case for Barrick Gold in this week's
Upvote Downvote

 
Primero Closes Sale of Cerro del Gallo

2017-11-27 marketwired
(Please note that all dollar amounts in this news release are expressed in U.S. dollars unless otherwise indicated.)
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...